DEBINT4.GIF (10584 bytes)

European Union funded research
 
Project name:
Rare genetic skin diseases: advancing diagnosis, management and awareness through a European network

Project acronym: GENESKIN

Project type: Coordination Action

European Commission Research Programme: 6th FP "Life Sciences, Genomics and Biotechnology for Health"

European Commission grant: €1.2 million

 

AIMS

 

Concerned with all genetic skin diseases (300), covering 5 major disease categories:

  • epithelial adhesion disorders (Epidermolysis Bullosa, Kindler syndrome etc)
  • keratinisation disorders
  • ectodermal dysplasias
  • connective tissue diseases
  • DNA repair disorders

1 For each group, a clinical and laboratory network will generate and disseminate:

  • a list of reference centres with the services offered
  • diagnostic questionnaires/protocols
  • gene cards, mutation database, diagnostic reagent list
  • ongoing clinical trial list

2 Whilst not directly funding research it will coordinate:

  • improved early post-natal and pre-natal diagnosis by novel immunohistochemical/biochemical and molecular tests
  • identification of new genes involved in genetic skin disease by collecting a sizeable number of biological samples
  • definition of genotype/phenotype correlation and characterisation of newly identified gene product functions by creation of a sample databank

3 Improved management of the conditions by training of clinicians and scientists

4 Pan-European communication amongst patient organisations, ethics committees, physicians and scientists

5 Information dissemination using a dedicated website

 

Partner organisations

  1. Istituto Dermopatico dell’Immacolata (IT) Project Co-ordinator
  2. Istituto di Genetica Molecolare-Consiglio Nazionale delle Richerche (IT)
  3. Universita di Modena e Reggio Emilia (IT)
  4. Institute of Genetics & Biophysics-Consiglio Nazionale delle Ricerche (IT)
  5. Universitaetsklinik Freiburg (DE)
  6. University Hospital Muenster (DE)
  7. Max Delbruck Centre for Molecular Medicine (DE)
  8. Philipps-Universitaet Marburg (DE)
  9. Kings College London (UK)
  10. Queen Mary & Westfield College London (UK)
  11. University of Sussex (UK)
  12. University of Glasgow (UK)
  13. DEBRA Europe (based in UK)
  14. Our Lady’s Hospital for Sick Children (IE)
  15. INSERM U385 (FR)
  16. Centre Hospitalier Universitaire de Nice (FR)
  17. Hopiteaux de Toulouse (FR)
  18. Centre National de la Recherche Scientifique (FR)
  19. Centre Hospitalo-Universitaire Necker Enfants Malades (FR)
  20. University V Segalen Bordeaux 2 & INSERM E207 (FR)
  21. Consortium National de Recherche en Genomique (FR)
  22. Centre Hospitalier Universitaire Vaudois (CH)
  23. Centre for Medical Genetics (BE)
  24. Erasmus Medical Centre (NL)
  25. Rijksuniversiteit Groningen (NL)
  26. Spanish Consortium for the development of new treatments for EB (ES)
  27. Federal Academic Hospital of Feldkirch (AT)
  28. General Hospital Salzburg, Paracelsus Medical University (AT)

About DebRA | About EB | Management of EB | Research | News & Events | Resources |

DebRA House  13 Wellington Business Park, Dukes Ride, Crowthorne, Berkshire RG45 6LS
Telephone: +44 (0) 1344 771961  Fax: +44 (0) 1344 762661
DebRA is a registered charity
Registered Charity No: 1084958
© DebRA international all rights reserved 2002